Annual Revenue
$36.85 M
+$10.27 M+38.65%
31 December 2023
Summary:
Mersana Therapeutics annual revenue is currently $36.85 million, with the most recent change of +$10.27 million (+38.65%) on 31 December 2023. During the last 3 years, it has risen by +$36.03 million (+4351.09%). MRSN annual revenue is now -12.51% below its all-time high of $42.12 million, reached on 31 December 2019.MRSN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$12.60 M
+$10.30 M+449.41%
30 September 2024
Summary:
Mersana Therapeutics quarterly revenue is currently $12.60 million, with the most recent change of +$10.30 million (+449.41%) on 30 September 2024. Over the past year, it has increased by +$4.90 million (+63.65%). MRSN quarterly revenue is now -69.30% below its all-time high of $41.03 million, reached on 31 March 2019.MRSN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$34.84 M
+$4.90 M+16.37%
30 September 2024
Summary:
Mersana Therapeutics TTM revenue is currently $34.84 million, with the most recent change of +$4.90 million (+16.37%) on 30 September 2024. Over the past year, it has dropped by -$6.00 million (-14.70%). MRSN TTM revenue is now -28.27% below its all-time high of $48.57 million, reached on 31 March 2019.MRSN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.6% | +63.6% | -14.7% |
| 3 y3 years | +4351.1% | +10000.0% | +10000.0% |
| 5 y5 years | +247.9% | +1392.7% | -19.5% |
MRSN Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -14.2% | >+9999.0% | -14.7% | >+9999.0% |
| 5 y | 5 years | -12.5% | >+9999.0% | -14.2% | >+9999.0% | -19.5% | >+9999.0% |
| alltime | all time | -12.5% | >+9999.0% | -69.3% | >+9999.0% | -28.3% | >+9999.0% |
Mersana Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.60 M(+449.4%) | $34.84 M(+16.4%) |
| June 2024 | - | $2.29 M(-75.2%) | $29.94 M(-21.8%) |
| Mar 2024 | - | $9.24 M(-13.6%) | $38.30 M(+3.9%) |
| Dec 2023 | $36.85 M(+38.7%) | $10.70 M(+39.0%) | $36.85 M(-9.8%) |
| Sept 2023 | - | $7.70 M(-27.7%) | $40.84 M(+5.5%) |
| June 2023 | - | $10.65 M(+36.6%) | $38.72 M(+19.7%) |
| Mar 2023 | - | $7.80 M(-46.9%) | $32.35 M(+21.7%) |
| Dec 2022 | $26.58 M(>+9900.0%) | $14.69 M(+163.6%) | $26.58 M(+123.3%) |
| Sept 2022 | - | $5.57 M(+30.1%) | $11.90 M(+87.7%) |
| June 2022 | - | $4.28 M(+110.4%) | $6.34 M(+206.5%) |
| Mar 2022 | - | $2.04 M(>+9900.0%) | $2.07 M(+4602.3%) |
| Dec 2021 | $43.00 K(-94.8%) | $11.00 K(0.0%) | $44.00 K(0.0%) |
| Sept 2021 | - | $11.00 K(0.0%) | $44.00 K(0.0%) |
| June 2021 | - | $11.00 K(0.0%) | $44.00 K(-94.7%) |
| Mar 2021 | - | $11.00 K(0.0%) | $829.00 K(0.0%) |
| Dec 2020 | $828.00 K | $11.00 K(0.0%) | $829.00 K(-3.6%) |
| Sept 2020 | - | $11.00 K(-98.6%) | $860.00 K(-49.2%) |
| June 2020 | - | $796.00 K(+7136.4%) | $1.69 M(+54.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $11.00 K(-73.8%) | $1.10 M(-97.4%) |
| Dec 2019 | $42.12 M(+297.6%) | $42.00 K(-95.0%) | $42.12 M(-2.7%) |
| Sept 2019 | - | $844.00 K(+317.8%) | $43.27 M(-2.9%) |
| June 2019 | - | $202.00 K(-99.5%) | $44.58 M(-8.2%) |
| Mar 2019 | - | $41.03 M(+3351.2%) | $48.57 M(+358.4%) |
| Dec 2018 | $10.59 M(-39.6%) | $1.19 M(-44.7%) | $10.60 M(-16.4%) |
| Sept 2018 | - | $2.15 M(-48.7%) | $12.67 M(-24.5%) |
| June 2018 | - | $4.19 M(+36.8%) | $16.78 M(+2.8%) |
| Mar 2018 | - | $3.06 M(-6.0%) | $16.32 M(-7.0%) |
| Dec 2017 | $17.55 M(-30.3%) | $3.26 M(-48.0%) | $17.55 M(-33.2%) |
| Sept 2017 | - | $6.27 M(+68.2%) | $26.28 M(+12.9%) |
| June 2017 | - | $3.73 M(-13.1%) | $23.27 M(-9.7%) |
| Mar 2017 | - | $4.29 M(-64.2%) | $25.76 M(+2.4%) |
| Dec 2016 | $25.17 M(+143.0%) | $12.00 M(+267.7%) | $25.17 M(+91.1%) |
| Sept 2016 | - | $3.26 M(-47.5%) | $13.17 M(+32.9%) |
| June 2016 | - | $6.21 M(+68.1%) | $9.91 M(+168.1%) |
| Mar 2016 | - | $3.70 M | $3.70 M |
| Dec 2015 | $10.36 M | - | - |
FAQ
- What is Mersana Therapeutics annual revenue?
- What is the all time high annual revenue for Mersana Therapeutics?
- What is Mersana Therapeutics annual revenue year-on-year change?
- What is Mersana Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly revenue year-on-year change?
- What is Mersana Therapeutics TTM revenue?
- What is the all time high TTM revenue for Mersana Therapeutics?
- What is Mersana Therapeutics TTM revenue year-on-year change?
What is Mersana Therapeutics annual revenue?
The current annual revenue of MRSN is $36.85 M
What is the all time high annual revenue for Mersana Therapeutics?
Mersana Therapeutics all-time high annual revenue is $42.12 M
What is Mersana Therapeutics annual revenue year-on-year change?
Over the past year, MRSN annual revenue has changed by +$10.27 M (+38.65%)
What is Mersana Therapeutics quarterly revenue?
The current quarterly revenue of MRSN is $12.60 M
What is the all time high quarterly revenue for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly revenue is $41.03 M
What is Mersana Therapeutics quarterly revenue year-on-year change?
Over the past year, MRSN quarterly revenue has changed by +$4.90 M (+63.65%)
What is Mersana Therapeutics TTM revenue?
The current TTM revenue of MRSN is $34.84 M
What is the all time high TTM revenue for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM revenue is $48.57 M
What is Mersana Therapeutics TTM revenue year-on-year change?
Over the past year, MRSN TTM revenue has changed by -$6.00 M (-14.70%)